e.g. Filippa Pettersson or Cancer Res. 75(6) , 1102-12, (2015) or 10.1002/anie.201600521
Synthesis and pharmacological evaluation of aminopyrimidine series of 5-HT 1A partial agonists
…, BM Campbell, T Crawford, L Denny, LM Evans…
Index: Dounay, Amy B.; Barta, Nancy S.; Bikker, Jack A.; Borosky, Susan A.; Campbell, Brian M.; Crawford, Terry; Denny, Lynne; Evans, Lori M.; Gray, David L.; Lee, Pil; Lenoir, Edward A.; Xu, Wenjian Bioorganic and Medicinal Chemistry Letters, 2009 , vol. 19, # 4 p. 1159 - 1163
Aminopyrimidine 2 (4-(1-(2-(1H-indol-3-yl) ethyl) piperidin-3-yl)-N-cyclopropylpyrimidin-2- amine) emerged from a high throughput screen as a novel 5-HT1A agonist. This compound showed moderate potency for 5-HT1A in binding and functional assays, as well as moderate metabolic stability. Implementation of a strategy for improving metabolic stability by lowering the lipophilicity (cLogD) led to identification of methyl ether 31 (4-(1-(2-(1H-indol-3-yl) ...